Georgia officials' attempts to create a biotechnology building spree may be paying off.
Now, a company that tests new drugs on humans says it will expand its headquarters in suburban Atlanta.
Quintiles will invest $19 million in the project, which will double its size to 850 employees and consolidate its two Atlanta area offices under one roof in Marietta.
Company CEO Dennis Gillings says the local resources ensure his drug-testing business will grow.
"With the CDC here, with a lot of fabulous universities here, and a lot of medical schools and a lot of biotechnology companies, a lot of research entitles, clearly there’s a huge spread of capabilities here in the Atlanta area," he said.
Georgia ranks seventh in the nation in recruiting life-sciences companies. Officials say the industry brings the state prestige and well-paid jobs.
Now, a company that tests new drugs on humans says it will expand its headquarters in suburban Atlanta.
Quintiles will invest $19 million in the project, which will double its size to 850 employees and consolidate its two Atlanta area offices under one roof in Marietta.
Company CEO Dennis Gillings says the local resources ensure his drug-testing business will grow.
"With the CDC here, with a lot of fabulous universities here, and a lot of medical schools and a lot of biotechnology companies, a lot of research entitles, clearly there’s a huge spread of capabilities here in the Atlanta area," he said.
Georgia ranks seventh in the nation in recruiting life-sciences companies. Officials say the industry brings the state prestige and well-paid jobs.
